ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,960Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1006

$915K Total Retail Price of All Prescriptions

Rank: 53 out of 1006

551 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 551 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 551 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 10,967 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 751 619 1 1
AMLODIPINE BESYLATE 657 625 2 4
LEVOTHYROXINE SODIUM 570 485 3 2
ATORVASTATIN CALCIUM 528 480 4 5
LISINOPRIL 504 418 5 3
OMEPRAZOLE 363 298 6 9
LOSARTAN POTASSIUM 287 269 7 22
METOPROLOL TARTRATE 268 223 8 7
METOPROLOL SUCCINATE 264 250 9 12
FUROSEMIDE 229 203 10 6
HYDROCODONE-ACETAMINOPHEN 219 212 S3 11 25
ZOLPIDEM TARTRATE 204 194 12 14
NEXIUM 202 188 13 28
SYNTHROID 200 184 14 42
WARFARIN SODIUM 176 140 15 8
FLUTICASONE PROPIONATE 175 143 16 55
METFORMIN HCL 172 149 17 10
ESCITALOPRAM OXALATE 148 123 18 27
GLIMEPIRIDE 143 140 19 50
CRESTOR 136 123 20 18
ALLOPURINOL 122 108 21 31
TAMSULOSIN HCL 122 118 21 23
POTASSIUM CHLORIDE 118 89 23 30
DIOVAN 117 105 24 16
SPIRIVA 101 89 25 48
CITALOPRAM HBR 99 63 26 24
TRAMADOL HCL 99 82 26 35
ADVAIR DISKUS 94 91 28 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 74 29 38
OXYCODONE-ACETAMINOPHEN 90 86 S2 30 57
ISOSORBIDE MONONITRATE ER 89 88 31 59
AZITHROMYCIN 89 75 31 39
RAMIPRIL 84 47 33 79
HYDROCHLOROTHIAZIDE 83 83 34 11
PRAVASTATIN SODIUM 82 80 35 15
TRAZODONE HCL 82 48 35 21
LIPITOR 80 68 37 47
SINGULAIR 80 56 37 82
JANUMET 76 76 39 151
CLOPIDOGREL 76 74 39 46
GABAPENTIN 75 63 41 20
PLAVIX 73 59 42 61
KLOR-CON 10 71 71 43 226
POLYETHYLENE GLYCOL 3350 70 20 44 91
LANTUS 70 57 44 43
CIPROFLOXACIN HCL 68 59 46 75
VENLAFAXINE HCL ER 67 54 47 105
SERTRALINE HCL 65 46 48 19
CEFUROXIME 64 49 49 170
ZETIA 63 47 50 51
JANUVIA 60 60 51 49
DOXAZOSIN MESYLATE 59 46 52 87
LOVASTATIN 58 58 53 44
FINASTERIDE 58 58 53 76
PANTOPRAZOLE SODIUM 55 26 55 32
ROPINIROLE HCL 54 45 56 154
NIASPAN 52 29 57 212
BYSTOLIC 52 40 57 84
QUINAPRIL HCL 52 40 57 86
INSULIN SYRINGE 50 45 60 122
LEVEMIR FLEXPEN 50 30 60 173
PAROXETINE HCL 50 50 60 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.